TC
MED icon

Truvestments Capital’s Medifast MED Stock Holding History

Truvestments Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25
Closed -$448 – 1106
2024
Q4 		$448 Hold
25
– – ﹤0.01% 957
2024
Q3 		$487 Buy
+25
New +$482 ﹤0.01% 875
2024
Q2 		– Sell
-460
Closed -$17.6K – 494
2024
Q1 		$17.6K Sell
460
-212
-32% -$10.3K 0.01% 449
2023
Q4 		$45.2K Sell
672
-413
-38% -$28.8K 0.02% 334
2023
Q3 		$81.2K Sell
1,085
-47
-4% -$4.17K 0.04% 245
2023
Q2 		$104K Sell
1,132
-186
-14% -$16.6K 0.05% 232
2023
Q1 		$137K Sell
1,318
-1,688
-56% -$187K 0.07% 215
2022
Q4 		$347K Sell
3,006
-4,526
-60% -$527K 0.2% 98
2022
Q3 		$816K Sell
7,532
-43
-0.6% -$6.16K 0.51% 55
2022
Q2 		$1.37M Sell
7,575
-415
-5% -$74.3K 0.8% 48
2022
Q1 		$1.36M Sell
7,990
-606
-7% -$114K 0.75% 54
2021
Q4 		$1.8M Sell
8,596
-310
-3% -$64.1K 0.9% 45
2021
Q3 		$1.72M Buy
8,906
+353
+4% +$86.8K 0.95% 46
2021
Q2 		$2.42M Buy
8,553
+1,216
+17% +$330K 1.33% 18
2021
Q1 		$1.55M Buy
7,337
+879
+14% +$210K 0.88% 37
2020
Q4 		$1.27M Buy
6,458
+317
+5% +$56K 0.88% 36
2020
Q3 		$1.01M Buy
6,141
+5,178
+538% +$853K 0.91% 37
2020
Q2 		$133K Buy
+963
New +$88.4K 0.14% 121

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Truvestments Capital's MED Position: Q1 2025 in Review

Truvestments Capital sold out of Medifast (MED) in Q1 2025, closing a stake of 25 shares — an estimated $448 sold.

Truvestments Capital first reported a position in MED in Q2 2020 and held it in 18 quarters. The position peaked at $2.42M in Q2 2021. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Truvestments Capital reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Truvestments Capital sold 25 Medifast shares in Q1 2025, an estimated $448.
  • Truvestments Capital first reported a position in Medifast in Q2 2020 and held it in 18 quarters.
  • Truvestments Capital's Medifast position peaked at $2.42M in Q2 2021.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Truvestments Capital's 13F filing for Q1 2025, filed 14 May 2025.